HDAC6 is a microtubule-associated deacetylase
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Reversible acetylation of alpha-tubulin has been implicated in regulating microtubule stability and function. The distribution of acetylated alpha-tubulin is tightly controlled and stereotypic. Acetylated alpha-tubulin is most abundant in stable microtubules but is absent from dynamic cellular structures such as neuronal growth cones and the leading edges of fibroblasts. However, the enzymes responsible for regulating tubulin acetylation and deacetylation are not known. Here we report that a member of the histone deacetylase family, HDAC6, functions as a tubulin deacetylase. HDAC6 is localized exclusively in the cytoplasm, where it associates with microtubules and localizes with the microtubule motor complex containing p150(glued) (ref. 3). In vivo, the overexpression of HDAC6 leads to a global deacetylation of alpha-tubulin, whereas a decrease in HDAC6 increases alpha-tubulin acetylation. In vitro, purified HDAC6 potently deacetylates alpha-tubulin in assembled microtubules. Furthermore, overexpression of HDAC6 promotes chemotactic cell movement, supporting the idea that HDAC6-mediated deacetylation regulates microtubule-dependent cell motility. Our results show that HDAC6 is the tubulin deacetylase, and provide evidence that reversible acetylation regulates important biological processes beyond histone metabolism and gene transcription.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HDAC6 catalyzes the deacetylation of K40 in the α-tubulin subunit of the microtubule,24 thereby regulating microtubule dynamics”
From Histone deacetylase 6 structure and molecular basis of catalysis and inhibition (2016) · cites this paper as [24]
In the citing paper
“HDAC6, a tubulin deacetylase [24].”
From Elevated SGK1 increases Tau phosphorylation and microtubule instability in Alzheimer’s patient-derived cortical neurons (2026) · cites this paper as [24]
In the citing paper
“The histone deacetylase 6 (HDAC6) has also been implicated in tau deacetylation/acetylation [180].”
From Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation (2023) · cites this paper as [180]
In the citing paper
“HDAC6 was shown to be the deacetylase for a diverse set of substrates involved in tumourigenesis, such as HSP90, α-tubulin, cortactin and peroxiredoxins”
From A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth (2013) · cites this paper as Hubbert et al, 2002
In the citing paper
“HDAC6 knockout in mice does not lead to embryonic lethality”
From A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth (2013) · cites this paper as Hubbert et al, 2002
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Acetylation: a regulatory modification to rival phosphorylation?
Kouzarides, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.6.1176 · Cited by 1,160
Microtubules containing acetylated alpha-tubulin in mammalian cells in culture.
Piperno, G., LeDizet, M., & Chang, X. J. (1987) · The Journal of cell biology · doi:10.1083/jcb.104.2.289 · Cited by 873
Deacetylation of p53 modulates its effect on cell growth and apoptosis
Luo, J., Su, F., Chen, D., Shiloh, A., & Gu, W. (2000) · Nature · doi:10.1038/35042612 · Cited by 818
Three proteins define a class of human histone deacetylases related to yeast Hda1p
Grozinger, C. M., Hassig, C. A., & Schreiber, S. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.4868 · Cited by 770 · cited 1×
“At least 11 proteins predicted to be members of the HDAC family have been identified on the basis of homology within the catalytic domai”
BackgroundPiperno, G., & Fuller, M. T. (1985) · The Journal of cell biology · doi:10.1083/jcb.101.6.2085 · Cited by 757
p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2
Ito, A., Lai, C.-H., Zhao, X., Saito, S., Hamilton, M. H., Appella, E., & Yao, T.-P. (2001) · The EMBO Journal · doi:10.1093/emboj/20.6.1331 · Cited by 582
Self-citationMicrotubule Targeting of Substrate Contacts Promotes Their Relaxation and Dissociation
Kaverina, I., Krylyshkina, O., & Small, J. V. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.5.1033 · Cited by 480
Histone acetylation: chromatin in action
Wade, P. A., Pruss, D., & Wolffe, A. P. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01016-5 · Cited by 471
Furumai, R., Komatsu, Y., Nishino, N., Khochbin, S., Yoshida, M., & Horinouchi, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.87 · Cited by 412 · cited 1×
“Unlike other family members, HDAC6 is uniquely resistant to the potent HDAC inhibitors trapoxin-B (TPXb”
BackgroundSelf-citationRegulation of cytoplasmic dynein behaviour and microtubule organization by mammalian Lis1
Smith, D. S., Niethammer, M., Ayala, R., Zhou, Y., Gambello, M. J., Wynshaw-Boris, A., & Tsai, L.-H. (2000) · Nature Cell Biology · doi:10.1038/35041000 · Cited by 381
Cited by
Items 801–900 of 1,012
Messaoudi, K., Ali, A., Ishaq, R., Palazzo, A., Sliwa, D., Bluteau, O., Souquère, S., Muller, D., Diop, M. K., Rameau, P., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01690-2 · Cited by 54
Macquart, C., Jüttner, R., Rodríguez, B. M., Dour, C. L., Lefebvre, F., Chatzifrangkeskou, M., Schmitt, A., Gotthardt, M., Bonne, G., & Muchir, A. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy227 · Cited by 63
Purine/purine isoster based scaffolds as new derivatives of benzamide class of HDAC inhibitors
Nepali, K., Chang, T.-Y., Lai, M.-J., Hsu, K., Yen, Y., Lin, T. E., Lee, S., & Liou, J. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112291 · Cited by 53
Hildmann, C., Ninkovic, M., Dietrich, R., Wegener, D., Riester, D., Zimmermann, T., Birch, O. M., Bernegger, C., Loidl, P., & Schwienhorst, A. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.8.2328-2339.2004 · Cited by 51
“The closest homolog among human HDACs is HDAC6, a presumptive tubulin deacetylase (12).”
Development of HDAC Inhibitors Exhibiting Therapeutic Potential in T-Cell Prolymphocytic Leukemia
Toutah, K., Nawar, N., Timonen, S., Sorger, H., Raouf, Y. S., Bukhari, S., von Jan, J., Ianevski, A., Gawel, J. M., Olaoye, O. O., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00420 · Cited by 51
Effects of Histone Modification in Major Depressive Disorder
Wu, M.-S., Li, X., Liu, C., Xu, Q., Huang, J., Gu, S., & Chen, J. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210922150043 · Cited by 62
Acetylated α-tubulin K394 regulates microtubule stability to shape the growth of axon terminals
Saunders, H. A. J., Johnson-Schlitz, D. M., Jenkins, B., Volkert, P. J., Yang, S. Z., & Wildonger, J. (2022) · Current Biology · doi:10.1016/j.cub.2021.12.012 · Cited by 56
Wang, D. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609788085287 · Cited by 53
“HDAC6 catalyzes deacetylation of acetylated α-tubulin, thus altering the stability of the microtubules in cytoplasm [12].”
BackgroundDido3-dependent HDAC6 targeting controls cilium size
de Diego, A. S., Guerrero, A. A., Martínez‐A, C., & van Wely, K. H. M. (2014) · Nature Communications · doi:10.1038/ncomms4500 · Cited by 52
Histone Deacetylase 6 Represents a Novel Drug Target in the Oncogenic Hedgehog Signaling Pathway
Dhanyamraju, P. K., Holz, P. S., Finkernagel, F., Fendrich, V., & Lauth, M. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0481 · Cited by 51
“An important modulator of tubulin acetylation is histone deacetylase 6 (HDAC6), a mainly cytoplasmic member of the HDAC family that uses tubulin as one of its major substrates (8, 9).”
BackgroundCang, S., Ma, Y., Chiao, J.-W., & Liu, D. (2014) · Experimental Hematology and Oncology · doi:10.1186/2162-3619-3-5 · Cited by 51
“A representative blot from three or more independent experiments was shown. tubulin deacetylase HDAC6 [41] (data not shown).”
BackgroundInfluentialHDAC6 Deacetylates HMGN2 to Regulate Stat5a Activity and Breast Cancer Growth
Medler, T. R., Craig, J. M., Fiorillo, A. A., Feeney, Y. B., Harrell, J. C., & Clevenger, C. V. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0109 · Cited by 56
“HDAC6 deacetylates tubulin to regulate microtubule turnover and therefore, motility (51).”
Choi, S. Y., Kee, H. J., Jin, L., Ryu, Y., Sun, S., Kim, G. R., & Jeong, M. H. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.071 · Cited by 51
Uittenbogaard, M., Brantner, C. A., & Chiaramello, A. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0396-1 · Cited by 50
Effect of Dietary Fiber and Metabolites on Mast Cell Activation and Mast Cell-Associated Diseases
Folkerts, J., Stadhouders, R., Redegeld, F. A., Tam, S., Hendriks, R. W., Galli, S. J., & Maurer, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01067 · Cited by 61
“To explain the contradictory effects found on acetylation of the histones, Zhang et al. also assessed butyrate-induced acetylation of α -tubulin in mast cells (56), which is controlled by the tubulin-associated HDAC6 (62).”
Lee, C.-C., Cheng, Y.-C., Chang, C.-Y., Lin, C.-M., & Chang, J.-Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-35392-6 · Cited by 51
AcK-knowledge Reversible Acetylation
Cohen, T., & Yao, T.-P. (2004) · Science's STKE · doi:10.1126/stke.2452004pe42 · Cited by 51
Self-citationImbalance of Lysine Acetylation Contributes to the Pathogenesis of Parkinson’s Disease
Wang, R., Sun, H., Wang, G., & Ren, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197182 · Cited by 52
Arabidopsis RPD3-like histone deacetylases form multiple complexes involved in stress response
Feng, C., Cai, X., Su, Y., Li, L., Chen, S., & He, X. (2021) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2021.04.004 · Cited by 49
Histone deacetylase 10, a potential epigenetic target for therapy
Cheng, F., Zheng, B., Wang, J., Zhao, G., Yao, Z., Niu, Z., & He, W. (2021) · Bioscience Reports · doi:10.1042/bsr20210462 · Cited by 55
A kinesin-1 variant reveals motor-induced microtubule damage in cells
Budaitis, B. G., Badieyan, S., Yue, Y., Blasius, T. L., Reinemann, D. N., Lang, M. J., Cianfrocco, M. A., & Verhey, K. J. (2022) · Current Biology · doi:10.1016/j.cub.2022.04.020 · Cited by 59
Development of a potential PET probe for HDAC6 imaging in Alzheimer's disease
Bai, P., Mondal, P., Bagdasarian, F. A., Rani, N., Liu, Y., Gomm, A., Tocci, D. R., Choi, S. H., Wey, H., Tanzi, R. E., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.05.017 · Cited by 53
Kinesin KIF15 regulates tubulin acetylation and spindle assembly checkpoint in mouse oocyte meiosis
Zou, Y., Shan, M., Wan, X., Liu, J., Zhang, K., Ju, J., Xing, C., & Sun, S. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04447-3 · Cited by 53
Steimbach, R. R., Herbst‐Gervasoni, C. J., Lechner, S., Stewart, T. M., Klinke, G., Ridinger, J., Géraldy, M. N. E., Tihanyi, G., Foley, J. R., Uhrig, U., et al. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c05030 · Cited by 51
Absence of ataxin-3 leads to cytoskeletal disorganization and increased cell death
Rodrigues, A. J., Costa, M. D. C., Silva, T. L., Ferreira, D., Bajanca, F., Logarinho, E., & Maciel, P. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.07.004 · Cited by 56
Legros, S., Boxus, M., Gatot, J., Lint, C. M. V., Kruys, V., Kettmann, R., Twizere, J., & Dequiedt, F. (2011) · Oncogene · doi:10.1038/onc.2011.120 · Cited by 53
Basseville, A., Tamaki, A., Ieranò, C., Trostel, S. Y., Ward, Y., Robey, R. W., Hegde, R. S., & Bates, S. E. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2008 · Cited by 53
“To evaluate HDAC6 involvement in Q141K ABCG2 rescue, we treated Flp-In-293 Q141K cells with the HDAC6 inhibitor tubastatin (28).”
Enhancement of pomalidomide anti-tumor response with ACY-241, a selective HDAC6 inhibitor
North, B. J., Almeciga-Pinto, I., Tamang, D., Yang, M., Jones, S. S., & Quayle, S. N. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173507 · Cited by 49
Wu, J., He, Z., Yang, X., Li, K.-L., Wang, D.-L., & Sun, F.-L. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.04.021 · Cited by 52
Comparison of the Deacylase and Deacetylase Activity of Zinc-Dependent HDACs
McClure, J. J., Inks, E. S., Zhang, C., Peterson, Y. K., Li, J., Chundru, K., Lee, B., Buchanan, A., Miao, S., & Chou, C. J. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00321 · Cited by 49
“subcellular localization fidelity to this compartment.(39) This result explains why a previous study”
Parkin absence accelerates microtubule aging in dopaminergic neurons
Cartelli, D., Amadeo, A., Calogero, A. M., Casagrande, F., Gregorio, C. D., Gioria, M., Kuzumaki, N., Costa, I., Sassone, J., Ciammola, A., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.09.010 · Cited by 52
Anti-cancer effects of naturally derived compounds targeting histone deacetylase 6-related pathways
Lernoux, M., Schnekenburger, M., Dicato, M. A., & Diederich, M. F. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.11.004 · Cited by 55
Caspase-8 Cleaves Histone Deacetylase 7 and Abolishes Its Transcription Repressor Function
Scott, F. L., Fuchs, G. J., Boyd, S. E., Denault, J., Hawkins, C. J., Dequiedt, F., & Salvesen, G. S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800331200 · Cited by 56
Regulation of SV40 large T-antigen stability by reversible acetylation
Shimazu, T., Komatsu, Y., Nakayama, K. I., Fukazawa, H., Horinouchi, S., & Yoshida, M. (2006) · Oncogene · doi:10.1038/sj.onc.1209731 · Cited by 49
“However, acetylation of proteins is not limited to transcription factors. a-Tubulin has long been known as a protein to be acetylated, but recently it was shown that HDAC6 and SIRT2 are responsible for the deacetylation (Hubbert et al., 2002; Matsuyama et al., 2002; North et al., 2003).”
BackgroundSelf-citationThe role of histone deacetylase 6 in synaptic plasticity and memory
Perry, S., Kiragasi, B., Dickman, D., & Ray, A. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.01.028 · Cited by 49
“The second DAC domain is thought to be devoted exclusively to tubulin deacetylation (Hubbert et al., 2002), while the first DAC domain is associated with all other targets, including Bruchpilot (flies), cortactin (mammals) and potentially histones (Figure 3A, (Kovacs et al.”
BackgroundNonhistone targets of KAT2A and KAT2B implicated in cancer biology
Bondy‐Chorney, E., Denoncourt, A. M., Sai, Y., & Downey, M. (2018) · Biochemistry and Cell Biology · doi:10.1139/bcb-2017-0297 · Cited by 51
Histone deacetylase-6 modulates Tau function in Alzheimer's disease
Qureshi, T., & Chinnathambi, S. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2022.119275 · Cited by 56
Qin, T., Li, C., Xu, Y., Qin, Y., Jin, Y., He, R., Luo, Z., Zhao, J., Duan, C., Lü, H., et al. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.11.013 · Cited by 59
“Among HDACs, HDAC6 is the only HDAC located in the cyto-plasm, which regulates the deacetylation of non-histone structures or substrates and is involved in various physiological and pathological processes such as microtubule stabilization and autophagy [48].”
BackgroundMethodYoun, G. S., Ju, S. M., Choi, S. Y., & Park, J. (2015) · Glia · doi:10.1002/glia.22865 · Cited by 51
“HDAC6 deacetylates several substrates, including a-tubulin, cortactin, and heat shock protein 90 (Hubbert et al., 2002; reviewed in Li et al., 2013; Zhang et al., 2006).”
BackgroundLimited efficacy of specific HDAC6 inhibition in urothelial cancer cells
Rosik, L., Niegisch, G., Fischer, U., Jung, M., Schulz, W. A., & Hoffmann, M. J. (2014) · Cancer Biology & Therapy · doi:10.4161/cbt.28469 · Cited by 48
“HDAC6 overexpression promoted chemotactic movement of fibroblasts and lymphocytes, suggesting that HDAC6mediated tubulin deacetylation regulates microtubule-dependent cell motility.(55,56) Nevertheless, there is contradictory data on the importance of HDAC6 in regulation of cellular motility (reviewed in ref.”
BackgroundHistone deacetylase inhibition in the treatment of heart disease
Berry, J. M., Cao, D. J., Rothermel, B. A., & Hill, J. A. (2008) · Expert Opinion on Drug Safety · doi:10.1517/14740338.7.1.53 · Cited by 54
“• HDAC6 interacts with and deacetylates α -tubulin and microtubules [86,101] .”
BackgroundSrilunchang, K.-O., Krohn, N. G., & Dresselhaus, T. (2009) · Development · doi:10.1242/dev.035964 · Cited by 46
“The cytoplasmic protein histone deacetylase 6 (HDAC6), which mediates the transport of polyubiquitylated cargo to the aggresome (Hubbert et al., 2002; Kawaguchi et al., 2003) was recently found to interact with FAT10 in animal cells.”
BackgroundLee, K., Lo, H.-L., Tang, W.-C., Hsiao, H. H.-Y., & Yang, P. (2014) · Scientific Reports · doi:10.1038/srep06394 · Cited by 52
“Because a -tubulin deacetylation was found to enhance cell motility through a reduction in microtubule stability 35 , BBR may inhibit cell migration through the increased acetylation of a -tubulin.”
Optogenetic control of cofilin and αTAT in living cells using Z-lock
Stone, O. J., Pankow, N., Liu, B., Sharma, V. P., Eddy, R. J., Wang, H., Putz, A. T., Teets, F. D., Kuhlman, B., Condeelis, J. S., et al. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0405-4 · Cited by 48
PTG-0861: A novel HDAC6-selective inhibitor as a therapeutic strategy in acute myeloid leukaemia
Gawel, J. M., Shouksmith, A. E., Raouf, Y. S., Nawar, N., Toutah, K., Bukhari, S., Manaswiyoungkul, P., Olaoye, O. O., Israelian, J., Radu, T. B., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112411 · Cited by 41
Nam, H. J., Kang, J. K., Kim, S.-K., Ahn, K. J., Seok, H., Park, S. J., Chang, J., Pothoulakis, C., LaMont, J. T., & Kim, H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.162743 · Cited by 53
Repression of HIP/RPL29 expression induces differentiation in colon cancer cells
Liu, J., Huang, B. H., Zhang, J., Carson, D. D., & Hooi, S. C. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20589 · Cited by 50
Autophagy regulation by RNA alternative splicing and implications in human diseases
González-Rodríguez, P., Klionsky, D. J., & Joseph, B. (2022) · Nature Communications · doi:10.1038/s41467-022-30433-1 · Cited by 54
Bhuwania, R., Castro-Castro, A., & Linder, S. (2014) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2014.07.006 · Cited by 53
Reduced microtubule acetylation in cystic fibrosis epithelial cells
Rymut, S. M., Harker, A. J., Corey, D. A., Burgess, J. D., Sun, H., Clancy, J. P., & Kelley, T. J. (2013) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00411.2012 · Cited by 50
“In particular, HDAC6 is a cytosolic enzyme responsible for tubulin 64 deacetylation (15).”
BackgroundLiu, N., Xiong, Y., Li, S., Ren, Y., He, Q., Gao, S., Zhou, J., & Shui, W. (2015) · Scientific Reports · doi:10.1038/srep16869 · Cited by 48
Ustinova, K., Nováková, Z., Saito, M., Meleshin, M., Mikesova, J., Kutil, Z., Baranová, P., Havlínová, B., Schutkowski, M., Matthias, P., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011243 · Cited by 50
Sangalli, J. R., De, T. H. C., Perecin, F., Chiaratti, M. R., Oliveira, L. J., Araújo, R. R., Pimentel, J. R. V., Smith, L. C., & Meirelles, F. V. (2012) · Cellular Reprogramming · doi:10.1089/cell.2011.0079 · Cited by 50
“Moreover, the alterations observed in cellular morphology suggest an effect of these drugs on cytoskeleton since HDACs are responsible for microtubules dynamic (Hubbert et al., 2002).”
Metabolism, cytoskeleton and cellular signalling in the grip of protein N ϵ ‐ and O‐acetylation
Yang, X., & Grégoire, S. (2007) · EMBO reports · doi:10.1038/sj.embor.7400977 · Cited by 48
“This residue is conserved from humans to lower eukaryotes, such as Chlamydomonas, and its acetylation is preferentially associated with stable microtubules (Hubbert et al, 2002; Matsuyama et al, 2002; North et al, 2003; Zhang et al, 2003; reviewed by Boyault et al, 2007).”
BackgroundInhibition of histone deacetylases in melanoma—a perspective from bench to bedside
Hornig, E., Heppt, M. V., Graf, S. A., Ruzicka, T., & Berking, C. (2016) · Experimental Dermatology · doi:10.1111/exd.13089 · Cited by 50
Monoaminergic and Neuropeptidergic Neurons Have Distinct Expression Profiles of Histone Deacetylases
Takase, K., Oda, S., Kuroda, M., & Funato, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058473 · Cited by 47
“Another member of the class IIb HDAC family, HDAC6, has a highly similar catalytic domain as HDAC10 and deacetylates histones and cytoplasmic proteins such as alpha-tubulin, actin-binding protein, contactin, and heat shock chaperone protein HSP90 [20,35].”
BackgroundScherma, M., Qvist, J. S., Asok, A., Huang, S.-S. C., Masia, P., Deidda, M., Wei, Y. B., Soni, R. K., Fratta, W., Fadda, P., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1920866117 · Cited by 47
“HDAC6 is a class IIb HDAC, which was traditionally thought to localize in the cytoplasm, where it deacetylates microtubules (44).”
DEHP mediates drug resistance by directly targeting AhR in human breast cancer
Hsieh, T., Hsu, C., Yang, P., Chiu, C., Liang, S., Ou‐Yang, F., Kan, J., Hou, M., Wang, T., & Tsai, E. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112400 · Cited by 51
“Our previous study shows that AhR induces the expression of HDAC6 [15], which is a microtubule-associated deacetylase [48] that regulates cell–cell contact [49], EMT [50] and metastasis [51] in cancer.”
BackgroundEmerging Microtubule Targets in Glioma Therapy
Katsetos, C. D., Reginato, M. J., Baas, P. W., D’Agostino, L., Legido, A., Tuszyński, J. A., Dráberová, E., & Dráber, P. (2015) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2015.03.009 · Cited by 52
Histone Deacetylase 6 Is a FoxO Transcription Factor-dependent Effector in Skeletal Muscle Atrophy
Ratti, F., Ramond, F., Moncollin, V., Simonet, T., Milan, G., Méjat, A., Thomas, J.-L., Streichenberger, N., Gilquin, B., Matthias, P., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.600916 · Cited by 53
NEDD9 Regulates Actin Dynamics through Cortactin Deacetylation in an AURKA/HDAC6–Dependent Manner
Kozyreva, V. K., McLaughlin, S. L., Livengood, R. H., Calkins, R. A., Kelley, L. C., Rajulapati, A., Ice, R. J., Smolkin, M. B., Weed, S. A., & Pugacheva, E. N. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0654 · Cited by 47
“Hyperacetylation or loss of CTTN expression in mesenchymal cells impairs cell migration (22) through decreased lamellipodia persistence and stability (23).”
BackgroundAdriaenssens, E., Tedesco, B., Mediani, L., Asselbergh, B., Crippa, V., Antoniani, F., Carra, S., Poletti, A., & Timmerman, V. (2020) · Scientific Reports · doi:10.1038/s41598-020-65664-z · Cited by 51
Konno, A., Setou, M., & Ikegami, K. (2012) · International review of cytology · doi:10.1016/b978-0-12-394305-7.00003-3 · Cited by 59
Chromatin Modifications as Targets for New Anticancer Drugs
Schäfer, S., & Jung, M. (2005) · Archiv der Pharmazie · doi:10.1002/ardp.200500984 · Cited by 59
HDAC11 is a novel regulator of fatty acid oxidative metabolism in skeletal muscle
Hurtado, E., Núñez‐Álvarez, Y., Muñoz, M., Gutiérrez‐Caballero, C., Casas, J., Pendás, A. M., Peinado, M. A., & Suelves, M. (2020) · FEBS Journal · doi:10.1111/febs.15456 · Cited by 47
Sinatra, L., Vogelmann, A., Friedrich, F., Tararina, M. A., Neuwirt, E., Colcerasa, A., König, P., Toy, L., Yesiloglu, T. Z., Hilscher, S., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01385 · Cited by 47
Banerjee, S., Jana, S., Jha, T., Ghosh, B., & Adhikari, N. (2024) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2024.108051 · Cited by 49
Polarity Regulation in Migrating Neurons in the Cortex
Reiner, O., & Sapir, T. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8065-0 · Cited by 49
Zhou, Q. Y., Chaerkady, R., Shaw, P. G., Kensler, T. W., Pandey, A., & Davidson, N. E. (2010) · PROTEOMICS · doi:10.1002/pmic.200900602 · Cited by 46
“Our results identified the previously recognized HDAC targets, tubulin (a and b), and actin [8, 27, 28].”
Berbari, N. F., Sharma, N., Malarkey, E. B., Pieczynski, J. N., Boddu, R., Gaertig, J., Guay‐Woodford, L. M., & Yoder, B. K. (2012) · Cytoskeleton · doi:10.1002/cm.21088 · Cited by 52
“…mutants could also be due to an inability to deacetylate the microtubule, we analyzed expression and localization of histone deacetylase 6 (HDAC6), a key enzyme involved in regulating a-tubulin acetylation and microtubule dynamics [Hubbert et al., 2002; Zhang et al., 2003; Zilberman et al., 2009].”
BackgroundMolecular and Biologic Analysis of Histone Deacetylase Inhibitors with Diverse Specificities
Newbold, A., Matthews, G. M., Bots, M., Cluse, L. A., Clarke, C. J. P., Banks, K.-M., Cullinane, C., Bolden, J. E., Christiansen, A. J., Dickins, R. A., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0626 · Cited by 46
“Consistent with the HDAC-specific inhibitory properties of the two agents, both vorinostat and MRLB-223 induced histone hyperacetylation; however, only vorinostat induced acetylation of a-tubulin, a function known to be regulated by HDAC6 (37).”
BackgroundThe store-operated Ca 2+ entry-mediated signaling is important for cancer spread
Chen, Y., Hsu, K., & Shen, M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.11.030 · Cited by 55
Effects of mutating α-tubulin lysine 40 on sensory dendrite development
Jenkins, B., Saunders, H. A. J., Record, H. L., Johnson-Schlitz, D. M., & Wildonger, J. (2017) · Journal of Cell Science · doi:10.1242/jcs.210203 · Cited by 46
“The function of microtubule acetylation in the developing nervous system has been investigated mainly through the loss or overexpression of the primary α-tubulin acetyltransferase and deacetylase enzymes αTAT1 and HDAC6, respectively (Akella et al., 2010; Hubbert et al., 2002; Shida et al., 2010).”
BackgroundHDAC6 differentially regulates autophagy in stem-like versus differentiated cancer cells
Sharif, T., Martell, E., Dai, C., Ghassemi-Rad, M. S., Hanes, M. R., Murphy, P. J., Margam, N. N., Parmar, H. B., Giacomantonio, C. A., Duncan, R., et al. (2018) · Autophagy · doi:10.1080/15548627.2018.1548547 · Cited by 49
Cleophas, M. C. P., Crișan, T. O., Klück, V., Hoogerbrugge, N., Netea-Maier, R. T., Dinarello, C. A., Netea, M. G., & Joosten, L. A. B. (2019) · Arthritis Research & Therapy · doi:10.1186/s13075-019-1834-x · Cited by 47
HDAC6 inhibitors: Translating genetic and molecular insights into a therapy for axonal CMT
Rossaert, E., & Van Den Bosch, L. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146692 · Cited by 45
Rodrigues, D. A., Guerra, F. S., Sagrillo, F. S., Pinheiro, P. D. S. M., Alves, M. A., Thota, S., Chaves, L. D. S., Sant’Anna, C. M. R., Fernandes, P. D., & Fraga, C. A. M. (2020) · ChemMedChem · doi:10.1002/cmdc.201900716 · Cited by 49
Ilan, Y. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04513-1 · Cited by 52
“MT hyperacetylation reduces adhesion turnover and cell motility [106], and MT deacetylation destabilizes MTs enabling them to impact other molecules and facilitate cell motility [107, 108].”
BackgroundSantander, V. S., Bisig, C. G., Purro, S. A., Casale, C. H., Arce, C. A., & Barra, H. S. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9212-9 · Cited by 45
“Since the tubulin acetylating enzyme seems to prefer microtubules as substrate, the stabilizing effect of taxol has been used to increase the amount of acetylated tubulin in cells [12, 13, 23].”
BackgroundResultChiba, Y., Takei, S., Kawamura, N., Kawaguchi, Y., Sasaki, K., Hasegawa‐Ishii, S., Furukawa, A., Hosokawa, M., & Shimada, A. (2012) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2011.01229.x · Cited by 45
Self-citationDu, Y., Wang, F., Zou, J., Le, W., Dong, Q., Wang, Z., Shen, F., Yu, L., & Li, Y. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.04.029 · Cited by 48
Carbamate Prodrug Concept for Hydroxamate HDAC Inhibitors
Schlimme, S., Hauser, A., Carafa, V., Heinke, R., Kannan, S., Stolfa, D. A., Cellamare, S., Carotti, A., Altucci, L., Jung, M., et al. (2011) · ChemMedChem · doi:10.1002/cmdc.201100007 · Cited by 45
Epigenomics and Ovarian Carcinoma
Maldonado, L., & Hoque, M. O. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.10.72 · Cited by 49
Kim, D. J., Martinez‐Lemus, L. A., & Davis, G. E. (2013) · Blood · doi:10.1182/blood-2012-11-470179 · Cited by 47
Belinostat: a new broad acting antineoplastic histone deacetylase inhibitor
Gimsing, P. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780902852560 · Cited by 53
“Platinums (carboplatin/cisplatin) and taxanes (paclitaxel/• docetaxel) [21,28]: the mechanism underlying this synergy is thought to involve augmentation of DNA damage by carboplatin (enhancement of DNA damage markers are found) and acetylation of tubulin (a substrate for HDAC6 [29]) by the taxanes.”
BackgroundBush, K. A., Krukowski, K., Eddy, J. L., Janusek, L. W., & Mathews, H. L. (2012) · Cellular Immunology · doi:10.1016/j.cellimm.2012.02.014 · Cited by 45
“GR’s subcellular location is determined by the accessibility of GR’s nuclear localization signals and nuclear retention signal [11].”
BackgroundHassig, C. A., Symons, K. T., Guo, X., Nguyen, P.-M., Annable, T., Wash, P. L., Payne, J. E., Jenkins, D. A., Bonnefous, C., Trotter, C., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2347 · Cited by 49
Primary Cilia in Tumor Biology: The Primary Cilium as a Therapeutic Target in Cholangiocarcinoma
Gradilone, S. A., Pisarello, M. J. L., & LaRusso, N. F. (2015) · Current Drug Targets · doi:10.2174/1389450116666150223162737 · Cited by 50
“HDAC6 is a member of the histone deacetylase family of proteins that is localized exclusively in the cytoplasm, and functions as a tubulin deaceylase [62].”
BackgroundHDAC6 Deacetylase Activity Is Required for Hypoxia-Induced Invadopodia Formation and Cell Invasion
Arsenault, D., Brochu‐Gaudreau, K., Charbonneau, M., & Dubois, C. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055529 · Cited by 51
“through the regulation of the levels of tubulin acetylation [59].”
BackgroundEpigenetic Treatment of Neurological Disease
Gray, S. G. (2011) · Epigenomics · doi:10.2217/epi.11.67 · Cited by 46
Ciliopathies: Does HDAC6 Represent a New Therapeutic Target?
Yu, F. D., Ran, J., & Zhou, J. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.11.002 · Cited by 49
“With respect to the deacetylasedependent function, HDAC6 has been shown to deacetylate several substrates, including /-tubulin and cortactin [5–8].”
BackgroundWu, J.-Y., Xiang, S., Zhang, M., Fang, B., Huang, H., Kwon, O. K., Zhao, Y., Yang, Z., Bai, W., Bepler, G., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.795955 · Cited by 47
A novel class of anthraquinone-based HDAC6 inhibitors
Song, Y., Lim, J., & Seo, Y. H. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.12.056 · Cited by 45
Cuadrado-Tejedor, M., Pérez-González, M., García-Muñoz, C., Muruzabal, D., García-Barroso, C., Rabal, O., Segura, V., Sánchez-Arias, J. A., Oyarzabal, J., & Garcia-Osta, A. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00149 · Cited by 44
“By contrast, the inhibition (or reduction) of HDAC6, a cytoplasmic HDAC isoform that regulates microtubule behavior and stability via α-tubulin acetylation (Hubbert et al., 2002), seems to promote tau and Aβ clearance, thereby ameliorating the memory deficits in AD models (Cook et al.”
BackgroundHDAC6 Regulates LPS-Tolerance in Astrocytes
Beurel, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025804 · Cited by 47
“Acetylated-tubulin is a substrate of HDAC6, so increased acetyl-tubulin is a marker of HDAC6 inhibition [24,25].”
Schatten, H., & Sun, Q. (2015) · Reproduction Fertility and Development · doi:10.1071/rd14493 · Cited by 45
“HDAC6 and SIRT2 catalyse the removal of the acetyl group (Hubbert et al. 2002; Matsuyama et al. 2002; North et al. 2003; Garnham and Roll-Mecak 2012).”
BackgroundThe viral control of cellular acetylation signaling
Caron, C., Col, E., & Khochbin, S. (2002) · BioEssays · doi:10.1002/bies.10202 · Cited by 50
“Finally, there are also many, yet to be identified, critical cellular events that may rely on acetylation such as the control of protein ubiquitination,((9)) microtubule dynamic((10)) and intracellular trafficking((8)) that viruses may modify in order to escape different cellular defense mechanisms.”
Youn, G. S., Cho, H., Kim, D., Choi, S. Y., & Park, J. (2017) · Redox Biology · doi:10.1016/j.redox.2017.05.001 · Cited by 44
“HDAC6 consists of two homologous catalytic domains and a C-terminal ubiquitin-binding zinc-finger domain [14,15].”
BackgroundInter-relationship of Histone Deacetylase-6 with Tau-cytoskeletal organization and remodeling
Balmik, A. A., & Chinnathambi, S. (2022) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2022.151202 · Cited by 46
Pleskač, P., Fargeas, C. A., Veselská, R., Corbeil, D., & Skoda, J. (2024) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00554-0 · Cited by 51
“Besides its interactions with acetylated microtubules, polyubiquitinated misfolded proteins and dynein motors [364, 366, 367], HDAC6 binds via its second catalytic domain to the CD133 IC1, and thus stabilizes CD133 and prevents its degradation in the endosomal-lysosomal pathway [190, 362].”
Background
Metadata
- Authors
- Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., Yoshida, M., Wang, X.-F., & Yao, T.-P.
- Affiliations
- Duke University (US)
- Japan Science and Technology Agency (JP)
- Corresponding author
- Yao, Tso-Pang
- Venue
- Nature
- Published
- 2002-05
- Volume
- 417
- Issue
- 6887
- Pages
- 455-458
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2064959533
- Cited by
- 2,403
- References
- 21
- Citations by year
- 2026: 96 · 2025: 116 · 2024: 116 · 2023: 126 · 2022: 117 · 2021: 139 · 2020: 130 · 2019: 122 · 2018: 112 · 2017: 102 · 2016: 102 · 2015: 117 · 2014: 119 · 2013: 117 · 2012: 122
- FWCI
- 15.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- U.S. Department of Defense
- Damon Runyon Cancer Research Foundation
- World Bank Group
- Robert Bosch Stiftung
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- HDAC6, alpha-tubulin acetylation, microtubule stability, p150Glued, cell motility, chemotaxis, histone deacetylase
- MeSH terms
- Histone Deacetylase 6, Acetylation, Animals, Chemotaxis, Histone Deacetylases, Microtubule-Associated Proteins, Microtubules, Protein Binding, Tubulin, 3T3 Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.